GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medinice SA (WAR:ICE) » Definitions » YoY Rev. per Sh. Growth

Medinice (WAR:ICE) YoY Rev. per Sh. Growth : 0.00% (As of Mar. 2024)


View and export this data going back to 2018. Start your Free Trial

What is Medinice YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. Medinice's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was 0.00%.

Medinice's Revenue per Share for the three months ended in Mar. 2024 was zł0.01.

Medinice YoY Rev. per Sh. Growth Historical Data

The historical data trend for Medinice's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medinice YoY Rev. per Sh. Growth Chart

Medinice Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial - 76.32 -28.36 -20.83 -7.89

Medinice Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -18.18 - -11.11 -11.11 -

Medinice YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

Medinice's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(0.035-0.038)/ | 0.038 |
=-7.89 %

Medinice's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(0.009-0.009)/ | 0.009 |
=0.00 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medinice YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of Medinice's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Medinice (WAR:ICE) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medinice SA (WAR:ICE) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
WAR:INM WAR:CMI WAR:NST WAR:GMZ WAR:ADV WAR:MTN WAR:MSM WAR:GMT WAR:SDS WAR:MDG ABT SYK MDT BSX SZSE:300760 EW DXCM ZBH STE XAMS:PHIA
Traded in Other Exchanges
N/A
Address
ul. Karola Olszewskiego 6, Kielce, POL, 25-663
Website
http://www.medinice.pl
Medinice SA is a Polish company operating in the MedTech industry. The company is engaged in creating, developing and commercializing solutions in the field of medicine, in particular, cardiology and cardio surgery. Its portfolio includes close around 12 projects including CathAIO, an electrode with universal diagnostic, electrophysiological, haemodinamic and biohemic functions and can be used for RF ablation; cryoapplicator, for minimally invasive cardiosurgical cryoablation; Med-iConsole allows to reduce the need to use multiple computer devices during electrophysiological treatment; Minimax and Pacepress.